An innovative method that offers both patients and the doctors substantial advantages in Benign Prostatic Hyperplasia (BPH) therapy
Benign Prostatic Hyperplasia (BPH), commonly known as Prostate Enlargement, is the most common cause of voiding disorder in men over 50 years of age. The hyperplastic tissue constricts the urethra and lead to lower urinary tract symptoms (LUTS) such as Obstructive and Irritative. These conditions impact patient’s quality of life quite dramatically. There are medical therapies available for BPH, but when symptoms cannot be alleviated by the medical therapy, surgical intervention is recommended.
Given the high prevalence of BPH, it is important to have a therapy that combines high efficacy, cost-efficiency and optimal therapeutic outcomes with the lowest possible side effects. Particularly, pre and post-surgical complications like bleeding or TUR syndrome are at the forefront of patient’s interest. Thus came into existence – TURis: An innovative method that offers both patients and the doctors substantial advantages in Prostate Enlargement therapy.
TURis (Transurethral Resection in Saline) Plasma Vaporization offers a minimally invasive therapeutic alternative to conventional prostate surgery (TURP), thus substantially enhancing safety in the surgical management of BPH and does so without sacrificing efficacy or cost-efficiency.